Electromed, Inc.
Datakwaliteit: 100%
ELMD
NYSE
Manufacturing
Measuring & Analyzing Instruments
€ 24,12
▼
€ 0,29
(-1,19%)
Marktkapitalisatie: 201,92 M
Prijs
€ 24,21
Marktkapitalisatie
201,92 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Revenue grew 15,67% annually over 5 years — strong growth
Earnings grew 46,35% over the past year
ROE of 19,94% — decent returns on equity
Generating 8,25 M in free cash flow
PEG of 0,67 suggests growth is underpriced
Cash machine — converts 91,75% of earnings into free cash flow
Groei
Revenue Growth (5Y)
15,67%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)16,97%
Earnings (1Y)46,35%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
19,94%
Boven sectorgemiddelde (-53,47%)
ROIC19,03%
Net Margin13,06%
Op. Margin16,66%
Veiligheid
Debt / Equity
N/A
Current Ratio4,86
Interest CoverageN/A
Waardering
PE (TTM|2027)
22,46 | 18,34
Boven sectorgemiddelde (-1,48)
P/B Ratio4,44
EV/EBITDA16,40
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 22,5 | -1,5 |
| P/B | 4,4 | 1,6 |
| ROE % | 19,9 | -53,5 |
| Net Margin % | 13,1 | -41,5 |
| Rev Growth 5Y % | 15,7 | 1,8 |
| D/E | — | 0,3 |
Koersdoel Analisten
4 analisten
Buy
Huidig
€ 24,12
Koersdoel
€ 37,00
€ 36,00
€ 37,00
€ 38,00
Vooruitzicht
Forward K/W
18,27
Forward WPA
€ 1,32
WPA Groei (sch.)
+20,0%
Omzet Sch.
80,86 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 1,32
€ 1,29 – € 1,36
|
80,86 M | 4 |
| FY2026 |
€ 1,10
€ 1,09 – € 1,11
|
72,53 M | 4 |
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| 2026 Q2 |
€ 0,30
€ 0,28 – € 0,31
|
19,25 M | 4 |
| 2026 Q1 |
€ 0,24
€ 0,22 – € 0,26
|
17,53 M | 4 |
Winstverassingen
Laatste 6 kwartalen
| Kwartaal | Geschat WPA | Werkelijk WPA | Verrassing |
|---|---|---|---|
| Q42025 | € 0,26 | € 0,32 | +23,1% |
| Q32025 | € 0,21 | € 0,25 | +22,0% |
| Q22025 | € 0,22 | € 0,25 | +16,3% |
| 2026-Q2 | € 0,30 | € 0,31 | +4,2% |
| 2026-Q1 | € 0,24 | € 0,25 | +3,1% |
| Q12025 | € 0,20 | € 0,21 | +5,0% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16,97% | Revenue Growth (3Y) | 15,39% |
| Earnings Growth (1Y) | 46,35% | Earnings Growth (3Y) | 54,29% |
| Revenue Growth (5Y) | 15,67% | Earnings Growth (5Y) | 33,65% |
| Profitability | |||
| Revenue (TTM) | 68,86 M | Net Income (TTM) | 8,99 M |
| ROE | 19,94% | ROA | 16,57% |
| Gross Margin | 78,23% | Operating Margin | 16,66% |
| Net Margin | 13,06% | Free Cash Flow (TTM) | 8,25 M |
| ROIC | 19,03% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 4,86 |
| Interest Coverage | N/A | Asset Turnover | 1,27 |
| Working Capital | 36,19 M | Tangible Book Value | 45,05 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 22,46 | Forward P/E | N/A |
| P/B Ratio | 4,44 | P/S Ratio | 2,93 |
| PEG Ratio | 0,67 | Forward PEG | N/A |
| EV/EBITDA | 16,40 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 4,09% | ||
| Market Cap | 201,92 M | Enterprise Value | 188,13 M |
| Per Share | |||
| EPS (Diluted TTM) | 1,03 | Revenue / Share | 8,26 |
| FCF / Share | 0,99 | OCF / Share | 1,09 |
| EPS CAGR (1Y) | 46,55% | EPS CAGR (5Y) | 33,20% |
| EPS CAGR (10Y) | 13,59% | ||
| Efficiency | |||
| CapEx / Revenue | 1,28% | FCF Conversion | 91,75% |
| SBC-Adj. FCF | 5,68 M | Growth Momentum | 1,30 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 64,00 M | 54,72 M | 48,07 M | 41,66 M | 35,76 M |
| Net Income | 7,54 M | 5,15 M | 3,17 M | 2,31 M | 2,36 M |
| EPS (Diluted) | 0,85 | 0,58 | 0,36 | 0,26 | 0,27 |
| Gross Profit | 49,97 M | 41,73 M | 36,52 M | 31,44 M | 27,31 M |
| Operating Income | 9,66 M | 6,58 M | 4,01 M | 2,97 M | 3,14 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 996.000,0 | 656.000,0 | 916.000,0 | 1,36 M | 1,72 M |
| SG&A Expenses | 39,32 M | 34,49 M | 31,60 M | 27,11 M | 22,44 M |
| D&A | — | — | — | — | — |
| Interest Expense | — | 455.000,0 | 78.000,0 | 25.000,0 | 39.000,0 |
| Income Tax | 2,75 M | 1,89 M | 920.000,0 | 692.000,0 | 805.000,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 53,80 M | 52,23 M | 45,81 M | 41,36 M | 37,11 M |
| Total Liabilities | 10,59 M | 7,69 M | 8,14 M | 7,19 M | 4,69 M |
| Shareholders' Equity | 43,21 M | 44,55 M | 37,67 M | 34,17 M | 32,42 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 15,29 M | 16,08 M | 7,37 M | 8,15 M | 11,89 M |
| Current Assets | 45,08 M | 44,17 M | 37,79 M | 34,54 M | 31,70 M |
| Current Liabilities | 10,47 M | 7,68 M | 8,05 M | 7,15 M | 4,64 M |
{"event":"ticker_viewed","properties":{"ticker":"ELMD","listing_kind":"stock","pathname":"/stocks/elmd","exchange":"NYSE","country":"US"}}